1. Home
  2. HMC vs ILMN Comparison

HMC vs ILMN Comparison

Compare HMC & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Honda Motor Company Ltd.

HMC

Honda Motor Company Ltd.

HOLD

Current Price

$32.66

Market Cap

36.2B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$218.57

Market Cap

32.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMC
ILMN
Founded
1946
1998
Country
Japan
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.2B
32.3B
IPO Year
2002
2000

Fundamental Metrics

Financial Performance
Metric
HMC
ILMN
Price
$32.66
$218.57
Analyst Decision
Hold
Hold
Analyst Count
1
17
Target Price
N/A
$124.24
AVG Volume (30 Days)
881.9K
1.7M
Earning Date
05-13-2026
04-30-2026
Dividend Yield
4.45%
N/A
EPS Growth
N/A
170.87
EPS
N/A
2.22
Revenue
N/A
$4,343,000,000.00
Revenue This Year
N/A
$6.47
Revenue Next Year
$4.36
$5.58
P/E Ratio
$40.40
$98.09
Revenue Growth
N/A
N/A
52 Week Low
$23.25
$88.00
52 Week High
$34.89
$231.81

Technical Indicators

Market Signals
Indicator
HMC
ILMN
Relative Strength Index (RSI) 65.99 59.45
Support Level $29.29 $117.73
Resistance Level $33.15 $231.81
Average True Range (ATR) 0.36 9.22
MACD -0.07 -0.37
Stochastic Oscillator 82.17 68.24

Price Performance

Historical Comparison
HMC
ILMN

About HMC Honda Motor Company Ltd.

Incorporated in 1948, Honda Motor was originally a motorcycle manufacturer. Today, the firm makes automobiles, motorcycles, and power products such as boat engines, generators, and lawnmowers. Including joint ventures, Honda sold 3.4 million light vehicles and 22.1 million motorcycles in fiscal 2026, and consolidated sales were JPY 21.8 trillion. Automobiles constitute 64% of revenue and motorcycles 18%, with the rest split between power products and financial services. Honda also makes robots and private jets.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: